GT200200138A - Vacunacion en dosis unica con mycoplasma hyopneumoniae - Google Patents
Vacunacion en dosis unica con mycoplasma hyopneumoniaeInfo
- Publication number
- GT200200138A GT200200138A GT200200138A GT200200138A GT200200138A GT 200200138 A GT200200138 A GT 200200138A GT 200200138 A GT200200138 A GT 200200138A GT 200200138 A GT200200138 A GT 200200138A GT 200200138 A GT200200138 A GT 200200138A
- Authority
- GT
- Guatemala
- Prior art keywords
- dose
- mycoplasma hyopneumoniae
- vaccination
- hyo
- animal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/87—Mycoplasma
Abstract
LA PRESENTE INVENCION SE REFIERE A PROCEDIMIENTOS PARA EL TRATAMIENTO O PREVENCION DE UNA ENFERMEDAD O TRASTORNO EN UN ANIMAL CAUSADA POR INFECCION POR MYCOPLASMA HYOPNEUMONIAE (M. HYO), MEDIANTE LA ADMINISTRACION A UN ANIMAL, A APROXIMADAMENTE LOS TRES A DIEZ DIAS DE EDAD, DE UNA DOSIS UNICA DE UNA CANTIDAD EFECTIVA DE UNA VACUNA DE M. HYO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US30263601P | 2001-07-02 | 2001-07-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200200138A true GT200200138A (es) | 2003-05-15 |
Family
ID=23168589
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200200138A GT200200138A (es) | 2001-07-02 | 2002-07-02 | Vacunacion en dosis unica con mycoplasma hyopneumoniae |
Country Status (42)
Families Citing this family (52)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MY129765A (en) | 2000-12-19 | 2007-04-30 | Wyeth Corp | Improved mycoplasma hyopneumoniae bacterin vaccine |
WO2006056841A1 (en) * | 2004-11-24 | 2006-06-01 | Pharmacia & Upjohn Company Llc | Multiple-strain mycoplasma hyopneumoniae vaccines |
US7700285B1 (en) | 2005-12-29 | 2010-04-20 | Boehringer Ingelheim Vetmedica, Inc. | PCV2 immunogenic compositions and methods of producing such compositions |
US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
UA95602C2 (ru) | 2004-12-30 | 2011-08-25 | Берингер Ингельхейм Ветмедика, Инк. | Иммуногенная композиция цвс2 и способы приготовления такой композиции |
US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
DK2371385T3 (en) | 2005-12-29 | 2015-11-30 | Boehringer Ingelheim Vetmed | Use of a PV2 immunogen composition for reduction of clinical symptoms in pigs |
EP3320919B1 (en) | 2005-12-29 | 2020-05-27 | Boehringer Ingelheim Animal Health USA Inc. | Multivalent pcv2 immunogenic compositions and methods of producing such compositions |
WO2007103042A2 (en) * | 2006-03-03 | 2007-09-13 | Merial Limited | Mycoplasma hyopneumoniae vaccine |
EP2099927A4 (en) * | 2006-11-22 | 2010-05-05 | Boehringer Ingelheim Vetmed | METHODS FOR REDUCING FLAMBEES OF DISEASES ASSOCIATED WITH PORCINIC CIRCOVIRUS |
EP2859900A1 (en) * | 2006-12-11 | 2015-04-15 | Boehringer Ingelheim Vetmedica, Inc. | Effective method of treatment of porcine circovirus and lawsonia intracellularis infections |
AU2007333857B2 (en) | 2006-12-15 | 2014-05-15 | Boehringer Ingelheim Animal Health USA Inc. | Treatment of pigs with PCV2 antigen |
EP1941903A1 (en) | 2007-01-03 | 2008-07-09 | Boehringer Ingelheim Vetmedica Gmbh | Prophylaxis and treatment of PRDC |
EP1958644A1 (en) | 2007-02-13 | 2008-08-20 | Boehringer Ingelheim Vetmedica Gmbh | Prevention and treatment of sub-clinical pcvd |
US7829274B2 (en) | 2007-09-04 | 2010-11-09 | Boehringer Ingelheim Vetmedica, Inc. | Reduction of concomitant infections in pigs by the use of PCV2 antigen |
MX2010005014A (es) | 2007-11-06 | 2010-06-30 | Wyeth Llc | Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante. |
BRPI0821456A2 (pt) * | 2007-12-31 | 2015-06-16 | Boehring Ingelheim Vetmedica Inc | Partícula similar à pcv2 orf2 com inserção de aminoácido estranho |
CN101236206B (zh) * | 2008-01-17 | 2014-10-15 | 中国兽医药品监察所 | 一种猪肺炎支原体重组抗原elisa检测试剂盒 |
CA2712006A1 (en) * | 2008-01-23 | 2009-10-15 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions |
US8444989B1 (en) * | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
NZ727616A (en) * | 2008-06-27 | 2018-06-29 | Zoetis Services Llc | Novel adjuvant compositions |
CN102448488B (zh) | 2009-06-04 | 2014-10-15 | 独立行政法人产业技术综合研究所 | 支原体感染症用疫苗 |
TWI627281B (zh) | 2009-09-02 | 2018-06-21 | 百靈佳殷格翰家畜藥品公司 | 降低pcv-2組合物殺病毒活性之方法及具有改良免疫原性之pcv-2組合物 |
CA2793959C (en) | 2010-03-25 | 2019-06-04 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
PL2569007T3 (pl) | 2010-05-11 | 2016-04-29 | Intervet Int Bv | Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki |
NZ606490A (en) * | 2010-07-26 | 2015-04-24 | Qu Biolog Inc | Immunogenic anti-inflammatory compositions |
US8546149B2 (en) | 2010-08-27 | 2013-10-01 | Intervet Inc. | Potency test for vaccine formulations |
BR112013004594B1 (pt) * | 2010-08-27 | 2020-07-28 | Intervet International B. V. | método para a determinação de um conteúdo de antígeno |
SI2691530T1 (en) | 2011-06-10 | 2018-08-31 | Oregon Health & Science University | CMV glycoproteins and recombinant vectors |
MX362166B (es) * | 2012-03-07 | 2018-12-14 | Ceva Sante Animale | Nueva vacuna veterinaria. |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
CA2896298C (en) | 2012-12-28 | 2024-01-16 | Boehringer Ingelheim Vetmedica Gmbh | Method of making a mycoplasma vaccine |
DK2938356T3 (da) | 2012-12-28 | 2020-07-27 | Boehringer Ingelheim Vetmedica Gmbh | Immunogen sammensætning som omfatter mycoplasma-antigener |
UA116431C2 (uk) * | 2013-02-05 | 2018-03-12 | Агрікалчерал Текнолоджи Рісьоч Інстітьют | Композиція для попередження інфекції mycoplasma spp. |
CN104338125A (zh) * | 2013-07-29 | 2015-02-11 | 普莱柯生物工程股份有限公司 | 一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用 |
WO2015042423A2 (en) | 2013-09-19 | 2015-03-26 | Zoetis Llc | Vaccine |
WO2015051099A1 (en) | 2013-10-02 | 2015-04-09 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 orf2 protein variant and virus like particles composed thereof |
US9951109B2 (en) * | 2013-11-21 | 2018-04-24 | Agricultural Technology Research Institute | Composition for preventing Mycoplasma spp. infection |
CN105012948B (zh) * | 2014-04-18 | 2019-07-30 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其应用 |
CN104248753B (zh) * | 2014-05-15 | 2017-07-28 | 普莱柯生物工程股份有限公司 | 一种疫苗组合物及其应用 |
BR102014014727B1 (pt) * | 2014-06-16 | 2018-04-03 | Ouro Fino Saúde Animal Ltda | COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae |
US9814769B2 (en) | 2014-09-30 | 2017-11-14 | Qatar University | Vaccines against pathogenic Escherichia coli and methods of using the same |
SG11201705737RA (en) | 2015-01-16 | 2017-08-30 | Zoetis Services Llc | Foot-and-mouth disease vaccine |
KR20160099223A (ko) * | 2015-02-12 | 2016-08-22 | 강원대학교산학협력단 | 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법 |
WO2018030878A1 (ko) * | 2016-08-12 | 2018-02-15 | 주식회사 이노백 | 재조합 단백질을 포함하는 돼지 마이코플라즈마 감염 예방용 백신 조성물 |
RU2668799C1 (ru) * | 2017-09-08 | 2018-10-02 | Эгрикалчурал Текнолоджи Рисерч Инститьют | Субъединичная вакцина против mycoplasma spp. |
CN108101969A (zh) * | 2017-11-13 | 2018-06-01 | 南京大爻网络科技有限公司 | 一种与猪支原体肺炎相关的抗原及其应用 |
RU2695679C1 (ru) * | 2018-09-11 | 2019-07-25 | Эгрикалчурал Текнолоджи Рисерч Инститьют | Субъединичная вакцина против mycoplasma spp. |
RU2759427C2 (ru) * | 2019-07-08 | 2021-11-12 | Эгрикалчурал Текнолоджи Рисерч Инститьют | Субъединичная вакцина против mycoplasma spp |
CN117305192A (zh) * | 2023-12-01 | 2023-12-29 | 北京瑞阳瑞泰生物科技有限公司 | 一种猪肺炎支原体rt02株、疫苗组合物及其应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252328A (en) | 1987-03-26 | 1993-10-12 | Martin Marietta Energy Systems, Inc. | Mycoplasma hyopneumoniae antigen and uses therefor |
EP0283840A3 (en) * | 1987-03-26 | 1989-08-09 | Ml Technology Ventures, L.P. | Mycoplasma hyopneumoniae antigen and uses therefor |
EP0307976B1 (en) | 1987-09-18 | 1993-06-23 | Akzo Nobel N.V. | Mycoplasma vaccine |
EP0527771A4 (en) | 1990-04-02 | 1993-05-05 | Synergen, Inc. | Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
ATE160699T1 (de) | 1990-05-29 | 1997-12-15 | American Cyanamid Co | Impfstoff gegen die pneumonie bei schweinen und verfahren zu seiner herstellung |
US6113916A (en) * | 1990-05-29 | 2000-09-05 | American Cyanamid Company | Method of enhancing cell mediated immune responses |
US5565205A (en) | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
EP0475185A1 (en) | 1990-08-27 | 1992-03-18 | Nippon Flour Mills Co., Ltd. | DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same |
US5338543A (en) * | 1992-02-27 | 1994-08-16 | Ambico, Inc. | Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
AU687750B2 (en) * | 1992-09-28 | 1998-03-05 | Wyeth Holdings Corporation | Method of enhancing cell mediated immune responses |
US5530874A (en) | 1993-02-02 | 1996-06-25 | 3Com Corporation | Network adapter with an indication signal mask and an interrupt signal mask |
WO1995009870A1 (en) | 1993-10-07 | 1995-04-13 | Iowa State University Research Foundation, Inc. | Characterization of mycoplasma hyopneumoniae adhesins |
AU711350B2 (en) | 1994-05-10 | 1999-10-14 | Zoetis Services Llc | Improved modified live BRSV vaccine |
US5788962A (en) | 1995-01-17 | 1998-08-04 | The Curators Of The University Of Missouri | DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures |
AUPN178995A0 (en) * | 1995-03-16 | 1995-04-13 | University Of Melbourne, The | Antigen composition |
ES2224273T3 (es) | 1996-09-30 | 2005-03-01 | University Of Arkansas | Metodo para producir inmunidad activa por medio de un conjugado de vacuna. |
EP0846468B1 (en) | 1996-12-05 | 2004-06-09 | Akzo Nobel N.V. | Non-virulent mycoplasma synoviae and vaccine thereof |
AU1535299A (en) | 1997-11-26 | 1999-06-15 | Iowa State University Research Foundation Inc. | Recombinant (mycoplasma hyopneumoniae) vaccine |
AU6128900A (en) * | 1999-09-29 | 2001-04-05 | Pfizer Products Inc. | Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof |
US6585981B1 (en) * | 2000-07-27 | 2003-07-01 | Regents Of The University Of Minnesota | Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
-
2002
- 2002-06-07 DK DK02735755.7T patent/DK1474067T4/en active
- 2002-06-07 HU HU0400434A patent/HU230246B1/hu unknown
- 2002-06-07 EP EP02735755.7A patent/EP1474067B2/en not_active Expired - Lifetime
- 2002-06-07 DK DK08167761.9T patent/DK2027873T3/en active
- 2002-06-07 CN CN200810186079.6A patent/CN101524532B/zh not_active Expired - Lifetime
- 2002-06-07 AU AU2002309109A patent/AU2002309109B2/en not_active Expired
- 2002-06-07 ES ES02735755.7T patent/ES2312580T5/es not_active Expired - Lifetime
- 2002-06-07 WO PCT/IB2002/002121 patent/WO2003003941A2/en active Application Filing
- 2002-06-07 MX MXPA03011599A patent/MXPA03011599A/es active IP Right Grant
- 2002-06-07 ES ES08167761.9T patent/ES2550458T3/es not_active Expired - Lifetime
- 2002-06-07 EP EP14182639.6A patent/EP2842569B1/en not_active Revoked
- 2002-06-07 OA OA1200300344A patent/OA12638A/en unknown
- 2002-06-07 DE DE60229666T patent/DE60229666D1/de not_active Expired - Lifetime
- 2002-06-07 CN CN201210389058.0A patent/CN102872456B/zh not_active Expired - Lifetime
- 2002-06-07 CN CN028133447A patent/CN1551781B/zh not_active Expired - Lifetime
- 2002-06-07 BR BR0210804-6A patent/BR0210804A/pt not_active Application Discontinuation
- 2002-06-07 PT PT14182639T patent/PT2842569T/pt unknown
- 2002-06-07 DK DK14182639.6T patent/DK2842569T3/da active
- 2002-06-07 EA EA200301323A patent/EA009901B1/ru not_active IP Right Cessation
- 2002-06-07 IL IL15934902A patent/IL159349A0/xx unknown
- 2002-06-07 ES ES14182639T patent/ES2729579T3/es not_active Expired - Lifetime
- 2002-06-07 CZ CZ2003-3466A patent/CZ305781B6/cs not_active IP Right Cessation
- 2002-06-07 AP APAP/P/2003/002937A patent/AP2003002937A0/en unknown
- 2002-06-07 AT AT02735755T patent/ATE412426T2/de active
- 2002-06-07 PT PT81677619T patent/PT2027873E/pt unknown
- 2002-06-07 SK SK1579-2003A patent/SK288010B6/sk unknown
- 2002-06-07 JP JP2003509957A patent/JP2005515162A/ja active Pending
- 2002-06-07 PL PL373367A patent/PL209773B1/pl unknown
- 2002-06-07 NZ NZ530106A patent/NZ530106A/en not_active IP Right Cessation
- 2002-06-07 CA CA2451626A patent/CA2451626C/en not_active Expired - Lifetime
- 2002-06-07 TN TNPCT/IB2002/002121A patent/TNSN03155A1/fr unknown
- 2002-06-07 YU YU102203A patent/YU102203A/sh unknown
- 2002-06-07 PT PT02735755T patent/PT1474067E/pt unknown
- 2002-06-07 KR KR10-2004-7000044A patent/KR20040030785A/ko not_active Application Discontinuation
- 2002-06-07 EP EP08167761.9A patent/EP2027873B8/en not_active Expired - Lifetime
- 2002-06-19 US US10/174,701 patent/US6846477B2/en not_active Ceased
- 2002-06-26 DO DO2002000431A patent/DOP2002000431A/es unknown
- 2002-06-26 TW TW091114057A patent/TWI329514B/zh not_active IP Right Cessation
- 2002-07-01 UY UY27366A patent/UY27366A1/es not_active Application Discontinuation
- 2002-07-01 PE PE2002000593A patent/PE20030285A1/es not_active Application Discontinuation
- 2002-07-01 AR ARP020102479A patent/AR034678A1/es not_active Application Discontinuation
- 2002-07-02 PA PA20028549701A patent/PA8549701A1/es unknown
- 2002-07-02 GT GT200200138A patent/GT200200138A/es unknown
- 2002-07-06 UA UA20031213200A patent/UA78707C2/uk unknown
-
2003
- 2003-12-12 ZA ZA2003/09698A patent/ZA200309698B/en unknown
- 2003-12-15 IS IS7076A patent/IS7076A/is unknown
- 2003-12-22 NO NO20035762A patent/NO342654B1/no not_active IP Right Cessation
- 2003-12-23 HR HR20031079A patent/HRP20031079A2/hr not_active Application Discontinuation
- 2003-12-31 MA MA27468A patent/MA27047A1/fr unknown
-
2004
- 2004-01-26 BG BG108546A patent/BG66481B1/bg unknown
- 2004-08-12 US US10/917,130 patent/US20050013823A1/en not_active Abandoned
-
2005
- 2005-01-13 HK HK05100335.9A patent/HK1068250A1/xx not_active IP Right Cessation
-
2009
- 2009-01-16 CY CY20091100059T patent/CY1108749T1/el unknown
- 2009-12-18 HK HK09111932.9A patent/HK1134900A1/xx not_active IP Right Cessation
-
2012
- 2012-03-02 US US13/411,232 patent/USRE44399E1/en not_active Expired - Lifetime
-
2013
- 2013-06-26 HK HK13107527.2A patent/HK1180224A1/zh not_active IP Right Cessation
-
2015
- 2015-08-27 HK HK15108334.1A patent/HK1207584A1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200200138A (es) | Vacunacion en dosis unica con mycoplasma hyopneumoniae | |
AR054844A1 (es) | Vacuna contra lawsonia y metodos de uso de la misma | |
CO5611162A2 (es) | Metodos para prevenir enfermedades reproductivas en el ganado vacuno | |
CY1108436T1 (el) | Χορηγηση καψαϊκινοειδων | |
CY1112851T1 (el) | Μεθοδος προληψης ή θεραπειας μολυνσης μ. τuβεrculosis | |
UY27186A1 (es) | Formulación farmacéutica | |
CR10726A (es) | Vacuna que comprende un adyuvante de emulsion de aceite en agua | |
CR11122A (es) | Vacuna de influenza de emulsion de aceite en agua | |
AR054139A1 (es) | Formulacion modificada y de liberacion inmediata de esferas de memantina | |
UY28398A1 (es) | Método y parche de inmunización por disposición de microproyección | |
AR049985A1 (es) | Tratamiento de combinacion para enfermedades malignas no hematologicas | |
AR064009A1 (es) | Metodo de inmunizacion contra los 4 serotipos del dengue | |
EA200970013A1 (ru) | Вакцинация против гриппа по схеме многократного введения с использованием безадъювантной дозы | |
ATE308341T1 (de) | Pharmazeutische formulierungen | |
AR018862A1 (es) | Formulacion farmaceutica de liberacion prolongada, mejorada para la administracion oral de nefazodona o una sal farmaceuticamente aceptable de la misma;forma de dosificacion oral que la comprende y uso de dicha formulacion para preparar dicha forma de dosificacion | |
ECSP21023398A (es) | Dosis unitaria de vacuna contra el dengue y administración de esta | |
UY27365A1 (es) | Vacuna de mycoplasma bovis y métodos para reducir la neumonía en animales | |
ECSP21051833A (es) | Combinación de dextrometorfano y bupropión para el tratamiento de depresión | |
CO2022012272A2 (es) | Vacunas contra el coronavirus y métodos de uso | |
AR032151A1 (es) | Uso de un farmaco anti-angiogenico en conjunto con un agente fotosensible para la preparacion de un medicamento para el tratamiento fotodinamico mejorado de la neovasculatura indeseada | |
ATE458496T1 (de) | Hiv-vakzine und anwendungsverfahren | |
GT200300064A (es) | Formulacion farmaceutica que comprende melatonina | |
AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv | |
CR9074A (es) | Agente para la profilaxis o tratamiento del sindrome metabolico | |
CL2004000767A1 (es) | Unidad de dosificacion oral que comprende un agente antagonista de bombas de protones y excipientes de caracter basico; procedimiento para su preparacion, utiles para tratar enfermedades causadas por una secrecion aumentada de acidos gastricos. |